» Articles » PMID: 35581633

NEAT1 Can Be a Diagnostic Biomarker in the Breast Cancer and Gastric Cancer Patients by Targeting XIST, Hsa-miR-612, and MTRNR2L8: Integrated RNA Targetome Interaction and Experimental Expression Analysis

Overview
Journal Genes Environ
Publisher Biomed Central
Date 2022 May 17
PMID 35581633
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The most frequent malignancy in women is breast cancer (BC). Gastric cancer (GC) is also the leading cause of cancer-related mortality. Long non-coding RNAs (lncRNAs) are thought to be important neurotic regulators in malignant tumors. In this study, we aimed to evaluate the expression level of NEAT1 and the interaction of this non-coding RNA with correlated microRNAs, lncRNAs, and mRNAs or protein coding genes, experimentally and bioinformatically.

Methods: For the bioinformatics analyses, we performed RNA-RNA and protein-protein interaction analyses, using ENCORI and STRING. The expression analyses were performed by five tools: Microarray data analysis, TCGA data analysis (RNA-seq, R Studio), GEPIA2, ENCORI, and real-time PCR experiment. qRT-PCR experiment was performed on 50 GC samples and 50 BC samples, compared to adjacent control tissue.

Results: Based on bioinformatics and experimental analyses, lncRNA NEAT1 have a significant down-regulation in the breast cancer samples with tumor size lower than 2 cm. Also, it has a significant high expression in the gastric cancer patients. Furthermore, NEAT1 have a significant interaction with XIST, hsa-miR-612 and MTRNR2L8. High expression of NEAT1 have a correlation with the lower survival rate of breast cancer samples and higher survival rate of gastric cancer patients.

Conclusion: This integrated computational and experimental investigation revealed some new aspects of the lncRNA NEAT1 as a potential prognostic biomarker for the breast cancer and gastric cancer samples. Further investigations about NEA1 and correlated mRNAs, lncRNAs, and microRNAs - specially the mentioned RNAs in this study - can lead the researchers to more clear information about the role of NEAT1 in the breast cancer and gastric cancer.

Citing Articles

Identification of Novel lncRNAs Related to Colorectal Cancer Through Bioinformatics Analysis.

Heidari R, Assadollahi V, Marashi S, Elahian F, Mirzaei S Biomed Res Int. 2025; 2025:5538575.

PMID: 39949372 PMC: 11824705. DOI: 10.1155/bmri/5538575.


MicroRNA‑96 promotes the proliferation and migration of breast cancer cells by inhibiting Smad7 expression.

Zhang X, Cong L, Yu R, Yu Q, Hou X, Zhou Y Oncol Lett. 2025; 29(3):151.

PMID: 39898288 PMC: 11783994. DOI: 10.3892/ol.2025.14897.


Inhibition of Mir-21-5p Affects the Expression of LNCRNA X-Inactive Specific Transcript and Induces Apoptosis in MCF-7 Breast Cancer Cells.

Nejaddehghan S, Zargar S, Oloomi M, Baesi K, Kouhsar M Iran J Public Health. 2024; 53(3):714-725.

PMID: 38919297 PMC: 11194654. DOI: 10.18502/ijph.v53i3.15154.


Molecular Mechanisms of Tumorgenesis and Metastasis of Long Non-coding RNA (lncRNA) NEAT1 in Human Solid Tumors; An Update.

Alshahrani M, Saleh R, Hjazi A, Bansal P, Kaur H, Deorari M Cell Biochem Biophys. 2024; 82(2):593-607.

PMID: 38750383 DOI: 10.1007/s12013-024-01287-9.


Chromatin-modifying protein 4C (CHMP4C) affects breast cancer cell growth and doxorubicin resistance as a potential breast cancer therapeutic target.

Jin X, Wang J, Wang Z, Pang W, Chen Y, Yang L J Antibiot (Tokyo). 2023; 77(2):93-101.

PMID: 37993600 DOI: 10.1038/s41429-023-00683-2.


References
1.
Kim H, Prokunina-Olsson L, Chanock S . Common genetic variants in miR-1206 (8q24.2) and miR-612 (11q13.3) affect biogenesis of mature miRNA forms. PLoS One. 2012; 7(10):e47454. PMC: 3471815. DOI: 10.1371/journal.pone.0047454. View

2.
Liu Y, Lu L, Wen D, Liu D, Dong L, Gao D . MiR-612 regulates invadopodia of hepatocellular carcinoma by HADHA-mediated lipid reprogramming. J Hematol Oncol. 2020; 13(1):12. PMC: 7006096. DOI: 10.1186/s13045-019-0841-3. View

3.
Wang X, Jiang G, Ren W, Wang B, Yang C, Li M . LncRNA NEAT1 Regulates 5-Fu Sensitivity, Apoptosis and Invasion in Colorectal Cancer Through the MiR-150-5p/CPSF4 Axis. Onco Targets Ther. 2020; 13:6373-6383. PMC: 7336013. DOI: 10.2147/OTT.S239432. View

4.
Zhang Q, Chen B, Liu P, Yang J . XIST promotes gastric cancer (GC) progression through TGF-β1 via targeting miR-185. J Cell Biochem. 2017; 119(3):2787-2796. DOI: 10.1002/jcb.26447. View

5.
Xing F, Liu Y, Wu S, Wu K, Sharma S, Mo Y . Loss of XIST in Breast Cancer Activates MSN-c-Met and Reprograms Microglia via Exosomal miRNA to Promote Brain Metastasis. Cancer Res. 2018; 78(15):4316-4330. PMC: 6072593. DOI: 10.1158/0008-5472.CAN-18-1102. View